Top Banner
BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015
45

BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Dec 16, 2015

Download

Documents

Lucinda Barrett
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

BC368

Fatty Acid SynthesisChapter 21 (21.1 only)

April 28, 2015

Page 2: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Overview of fatty acid biosynthesis

Occurs in the cytosol of certain animal tissues; e.g., liver and mammary gland

(Also occurs in plants and bacteria)

Uses acetyl-CoA, NADPH as starting materials

Produces a pool of palmitic acid (16:0) that can be further modified

Page 3: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fatty acid synthesis requires the cooperation of several metabolic pathways.

Pathway Integration

Page 4: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Overlap with carbohydrate metabolism

Excess carbs are transported to cytosol as citrate

OA ends up back in the matrix

Net result is acetyl-CoA in cytosol

Page 5: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Amino acid degradation leads to acetyl-CoA or citrate

Citrate is transported to cytosol

Net result is acetyl-CoA in cytosol

Overlap with protein metabolism

Fig 18-15

Page 6: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

The intermediate: malonyl-CoA

Malonyl-CoA is an “activated” form of acetyl-CoA used for fatty acid biosynthesis.

Page 7: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Formation of malonyl-CoAAcetyl-CoA carboxylase has three activities:biotin carrier proteinbiotin carboxylasetranscarboxylase

Bicarb is phosphorylated, then picked up by biotin

Biotin swinging arm transfers CO2 to acetyl-CoA

Page 8: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fatty acid synthase

Fatty acid synthase has seven different enzyme activities

Page 9: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fatty acid synthase

Fatty acid synthase has seven different enzyme activities

Adds two carbons every cycle through addition of malonyl- CoA and loss of CO2

Page 10: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fatty acyl synthase

Page 11: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Key Player: acyl carrier protein

“Macro” CoA, carries growing fatty acid chain via thioester

Page 12: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Initiation Stage

Step 1: loading of acetyl-CoA onto fatty acid synthase

Page 13: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Initiation Stage

Step 2: loading of malonyl- CoA onto fatty acid synthase

Page 14: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fig 21-2

4 steps:

CondensationReductionDehydrationReduction

Overview of Assembly

Stage

Page 15: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fig 21-2

4 steps:

CondensationReductionDehydrationReduction

Overview of Assembly Stage

Page 16: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Step 1: Condensation

Reaction of malonyl group with acetyl group to form acetoacetyl- ACP

Loss of CO2

Page 17: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Step 2: Reduction to alcohol

Page 18: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Step 3: Dehydration

Page 19: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Step 4: Reduction of double bond

Page 20: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Transfer to KS

Page 21: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Next cycle begins

Another malonyl group is linked to ACP

Page 22: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Palmitic acid modifications

Cell makes a pool of palmitic acid that it can elongate and/or desaturate in the ER.

Elongation system is very similar to synthesis: 2C units added from malonyl-CoA.

Page 23: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Desaturase reaction

Desaturation results in oxidation of NADPH.

O2 is reduced.

Page 24: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Essential fatty acids

omega-6

omega-3

Page 25: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Fig 21-12

Linoleic acid modifications

Linoleic acid can be modified to form essential precursors such as arachidonic acid.

Page 26: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Arachidonic acid as a precursor

Arachidonic acid is used to make prostaglandins, thromboxanes, and leukotrienes.

Page 27: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Arachidonic acid as a precursor

Two isozymes of COX:

COX-1 makes “good” prostaglandins that maintain the GI tract.COX-2 makes “bad” prostaglandins that cause pain and inflammation.

Page 28: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Arachidonic acid as a precursor

Many analgesics are inhibitors of prostaglandin synthesis (via COX).

Page 29: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Arachidonic acid as a precursor

Increased specificity for COX-2

Page 30: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Robert is a 59-year-old triathlete and marathon runner in excellent health. Eight months ago, he began taking Vioxx.

Case Study

Page 31: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.
Page 32: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.
Page 33: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.
Page 34: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.
Page 35: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Robert is a 59-year-old triathlete and marathon runner in excellent health. Eight months ago, he began taking Vioxx.

Suddenly, he drops dead of a massive heart attack, which is ruled an arrhythmia by the coroner. Robert had no prior history of heart trouble.

Case Study

Page 36: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Robert is a 59-year-old triathlete and marathon runner in excellent health. Eight months ago, he began taking Vioxx.

Suddenly, he drops dead of a massive heart attack, which is ruled an arrhythmia by the coroner. Robert had no prior history of heart trouble.

Case Study

Page 37: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.
Page 38: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.
Page 39: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Control of fatty acid synthesis

When an organism has more than enough metabolic fuel to meet its energy needs, the excess is converted to fatty acids and stored as triglycerides.

Insulin and citrate stimulate FA synthesis

Page 40: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Control of fatty acid synthesis

Fig 21-11

Page 41: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Acetyl-CoA Carboxylase

Page 42: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Reciprocal control

Fig 17-13

Page 43: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

INSIG2 is an ER protein that inhibits FA synthesis.

Page 44: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Platencin and platensimycin are new antibiotics from the soil bacterium Streptomyces platensis that inhibit bacterial (type II) FA synthesis.FabH~ KS; FabF=

elongation enzyme

Page 45: BC368 Fatty Acid Synthesis Chapter 21 (21.1 only) April 28, 2015.

Barb attended a well-woman clinic, where she was found to have serum triglyerides at 73 mM1 and cholesterol at 503 mg/dL2. After some initial prevarication, she admitted to drinking 3 bottles of vodka and 6 bottles of wine per week. When she discontinued alcohol, her triglycerides dropped to 2 mM and her cholesterol to 193 mg/dL. Three years later, she is your patient, presenting with an enlarged liver and high blood lipid levels. Liver biopsy indicated infiltration of the liver cells with fat.

What is wrong with Barb?How does this account for her symptoms?

1above 2.5 mM is considered “at risk”

2above 240 mg/dL is considered “at risk”

Case Study